Each year it seems two questions on cardiovascular disease are always asked. ‘What is the role of B-blockers in treating hypertension?’ and ‘Is rate control or rhythm control best in the management of Atrial Fibrillation?’ The latter is the subject of the latest RGH bulletin.
The recent publication of several studies, such as the AFFIRM and RACE study, which compared rhythm control with rate control in patients older than 65 years old, led to the conclusion that rhythm control is not superior to rate control as it neither improves patient survival rate or functional status nor reduces the risk of stroke in patients with AF.
If you like this post and what else you see on the blog please subscribe by RSS feed (the orange button) or by email. Visit my subscription page.